Very encouraging for mine ,late stage cancer.
Durable response ,72% progression free at 6 months...part A
Part B
Partial response rate of 50% in high risk patients ,partial response often means greater than 50% tumour shrinkage , after 3 months,,current disease control rate 4/6 or 66% of patients ,no toxicity ,once again very impressive for mine ,only a small number of patients but that was always the case ,it’s only a phase 1 trial.
If these percentages can be translated to greater numbers that would be very exciting.
- Forums
- ASX - By Stock
- IMM
- Ann: Immutep presents new TACTI-mel data at ICI Europe Summit
Ann: Immutep presents new TACTI-mel data at ICI Europe Summit, page-6
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
36.5¢ |
Change
-0.005(1.35%) |
Mkt cap ! $530.2M |
Open | High | Low | Value | Volume |
36.5¢ | 37.0¢ | 35.5¢ | $328.0K | 909.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 38094 | 35.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.5¢ | 29559 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6493 | 0.385 |
1 | 1181 | 0.375 |
3 | 15950 | 0.365 |
3 | 35000 | 0.355 |
7 | 181738 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.340 | 1054 | 1 |
0.365 | 30301 | 2 |
0.370 | 114492 | 3 |
0.375 | 41492 | 2 |
0.380 | 79650 | 3 |
Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |